ID   MAST1_HUMAN             Reviewed;        1570 AA.
AC   Q9Y2H9; O00114; Q8N6X0;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 2.
DT   12-OCT-2022, entry version 185.
DE   RecName: Full=Microtubule-associated serine/threonine-protein kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Syntrophin-associated serine/threonine-protein kinase;
GN   Name=MAST1 {ECO:0000312|HGNC:HGNC:19034};
GN   Synonyms=KIAA0973 {ECO:0000312|EMBL:BAA76817.1}, SAST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAA76817.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA76817.1};
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAB51171.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 390-1570.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, TISSUE SPECIFICITY, INVOLVEMENT IN MCCCHCM, VARIANTS MCCCHCM
RP   GLU-195 DEL; LYS-277 DEL; LEU-279 DEL AND SER-517, AND VARIANTS LEU-93;
RP   VAL-98; SER-517; THR-915 AND ARG-1177.
RX   PubMed=30449657; DOI=10.1016/j.neuron.2018.10.044;
RA   Tripathy R., Leca I., van Dijk T., Weiss J., van Bon B.W., Sergaki M.C.,
RA   Gstrein T., Breuss M., Tian G., Bahi-Buisson N., Paciorkowski A.R.,
RA   Pagnamenta A.T., Wenninger-Weinzierl A., Martinez-Reza M.F., Landler L.,
RA   Lise S., Taylor J.C., Terrone G., Vitiello G., Del Giudice E.,
RA   Brunetti-Pierri N., D'Amico A., Reymond A., Voisin N., Bernstein J.A.,
RA   Farrelly E., Kini U., Leonard T.A., Valence S., Burglen L., Armstrong L.,
RA   Hiatt S.M., Cooper G.M., Aldinger K.A., Dobyns W.B., Mirzaa G.,
RA   Pierson T.M., Baas F., Chelly J., Cowan N.J., Keays D.A.;
RT   "Mutations in MAST1 cause mega-corpus-callosum syndrome with cerebellar
RT   hypoplasia and cortical malformations.";
RL   Neuron 100:1354-1368(2018).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-269; TYR-1240 AND SER-1292.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Microtubule-associated protein essential for correct brain
CC       development (PubMed:30449657). Appears to link the dystrophin/utrophin
CC       network with microtubule filaments via the syntrophins. Phosphorylation
CC       of DMD or UTRN may modulate their affinities for associated proteins
CC       (By similarity). {ECO:0000250|UniProtKB:Q9R1L5,
CC       ECO:0000269|PubMed:30449657}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9BXM7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9BXM7};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9BXM7};
CC   -!- SUBUNIT: Interacts with the microtubules. Part of a low affinity
CC       complex that associates with, but is distinct from, the postsynaptic
CC       density. Interacts with SNTB2. {ECO:0000250|UniProtKB:Q9R1L5}.
CC   -!- INTERACTION:
CC       Q9Y2H9; P00533: EGFR; NbExp=3; IntAct=EBI-3385920, EBI-297353;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9R1L5};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q9R1L5}; Cytoplasmic
CC       side {ECO:0000250|UniProtKB:Q9R1L5}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q9R1L5}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q9R1L5}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q9R1L5}. Note=Also localized in the soma of
CC       neurons. Observed as punctate clusters in the processes of interneurons
CC       and along the cell body periphery. Colocalizes with syntrophins at the
CC       cell membrane. {ECO:0000250|UniProtKB:Q9R1L5}.
CC   -!- TISSUE SPECIFICITY: Expressed in fetal brain.
CC       {ECO:0000269|PubMed:30449657}.
CC   -!- DISEASE: Mega-corpus-callosum syndrome with cerebellar hypoplasia and
CC       cortical malformations (MCCCHCM) [MIM:618273]: An autosomal dominant
CC       neurodevelopmental disorder with onset in infancy. MCCCHCM is
CC       characterized by global developmental delay, impaired intellectual
CC       development, poor or absent speech, unsteady gait, ataxia, inability to
CC       walk, and variable brain abnormalities. Seizures and autistic features
CC       are observed in some patients. Brain imaging findings include an
CC       enlarged corpus callosum in the absence of megalencephaly, cerebellar
CC       hypoplasia, ventricular dilation, gyral abnormalities, and cortical
CC       malformations. {ECO:0000269|PubMed:30449657}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB51171.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAH27985.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA76817.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB023190; BAA76817.1; ALT_INIT; mRNA.
DR   EMBL; AC020934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AD000092; AAB51171.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC027985; AAH27985.2; ALT_INIT; mRNA.
DR   CCDS; CCDS32921.1; -.
DR   PIR; T45070; T45070.
DR   RefSeq; NP_055790.1; NM_014975.2.
DR   PDB; 2M9X; NMR; -; A=187-287.
DR   PDB; 3PS4; X-ray; 1.85 A; A/B/C/D=965-1057.
DR   PDBsum; 2M9X; -.
DR   PDBsum; 3PS4; -.
DR   AlphaFoldDB; Q9Y2H9; -.
DR   SMR; Q9Y2H9; -.
DR   BioGRID; 116632; 53.
DR   IntAct; Q9Y2H9; 211.
DR   STRING; 9606.ENSP00000251472; -.
DR   BindingDB; Q9Y2H9; -.
DR   ChEMBL; CHEMBL1163128; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9Y2H9; -.
DR   GlyConnect; 2057; 4 N-Linked glycans (1 site).
DR   GlyGen; Q9Y2H9; 2 sites, 4 Asn glycans (1 site), 4 N-linked glycans (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Y2H9; -.
DR   PhosphoSitePlus; Q9Y2H9; -.
DR   BioMuta; MAST1; -.
DR   DMDM; 60390226; -.
DR   EPD; Q9Y2H9; -.
DR   jPOST; Q9Y2H9; -.
DR   MassIVE; Q9Y2H9; -.
DR   MaxQB; Q9Y2H9; -.
DR   PaxDb; Q9Y2H9; -.
DR   PeptideAtlas; Q9Y2H9; -.
DR   PRIDE; Q9Y2H9; -.
DR   ProteomicsDB; 85788; -.
DR   Antibodypedia; 26218; 101 antibodies from 23 providers.
DR   DNASU; 22983; -.
DR   Ensembl; ENST00000251472.9; ENSP00000251472.3; ENSG00000105613.10.
DR   GeneID; 22983; -.
DR   KEGG; hsa:22983; -.
DR   MANE-Select; ENST00000251472.9; ENSP00000251472.3; NM_014975.3; NP_055790.1.
DR   UCSC; uc002mvm.4; human.
DR   CTD; 22983; -.
DR   DisGeNET; 22983; -.
DR   GeneCards; MAST1; -.
DR   HGNC; HGNC:19034; MAST1.
DR   HPA; ENSG00000105613; Group enriched (brain, pituitary gland, retina).
DR   MalaCards; MAST1; -.
DR   MIM; 612256; gene.
DR   MIM; 618273; phenotype.
DR   neXtProt; NX_Q9Y2H9; -.
DR   OpenTargets; ENSG00000105613; -.
DR   PharmGKB; PA134946727; -.
DR   VEuPathDB; HostDB:ENSG00000105613; -.
DR   eggNOG; KOG0605; Eukaryota.
DR   eggNOG; KOG0606; Eukaryota.
DR   GeneTree; ENSGT00940000157700; -.
DR   HOGENOM; CLU_000288_9_0_1; -.
DR   InParanoid; Q9Y2H9; -.
DR   OMA; GMREKSW; -.
DR   OrthoDB; 323328at2759; -.
DR   PhylomeDB; Q9Y2H9; -.
DR   TreeFam; TF313149; -.
DR   PathwayCommons; Q9Y2H9; -.
DR   SignaLink; Q9Y2H9; -.
DR   SIGNOR; Q9Y2H9; -.
DR   BioGRID-ORCS; 22983; 16 hits in 1106 CRISPR screens.
DR   ChiTaRS; MAST1; human.
DR   EvolutionaryTrace; Q9Y2H9; -.
DR   GeneWiki; MAST1; -.
DR   GenomeRNAi; 22983; -.
DR   Pharos; Q9Y2H9; Tchem.
DR   PRO; PR:Q9Y2H9; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9Y2H9; protein.
DR   Bgee; ENSG00000105613; Expressed in right hemisphere of cerebellum and 109 other tissues.
DR   ExpressionAtlas; Q9Y2H9; baseline and differential.
DR   Genevisible; Q9Y2H9; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   CDD; cd05609; STKc_MAST; 1.
DR   Gene3D; 1.20.1480.20; -; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR015022; MA_Ser/Thr_Kinase_dom.
DR   InterPro; IPR037711; MAST.
DR   InterPro; IPR028777; MAST1.
DR   InterPro; IPR023142; MAST_pre-PK_dom_sf.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR041489; PDZ_6.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24356:SF150; PTHR24356:SF150; 1.
DR   Pfam; PF08926; DUF1908; 1.
DR   Pfam; PF17820; PDZ_6; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF140482; SSF140482; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Cell projection; Cytoplasm;
KW   Cytoskeleton; Disease variant; Intellectual disability; Kinase; Magnesium;
KW   Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..1570
FT                   /note="Microtubule-associated serine/threonine-protein
FT                   kinase 1"
FT                   /id="PRO_0000086309"
FT   DOMAIN          374..647
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          648..719
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   DOMAIN          967..1055
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          23..80
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          94..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          139..171
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          340..374
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          717..909
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          929..965
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1065..1184
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1200..1293
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1305..1570
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        32..46
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        62..78
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        140..154
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        357..373
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        740..760
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        808..823
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        934..965
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1078..1094
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1097..1177
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1221..1239
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1278..1293
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        497
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXM7,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         380..388
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXM7,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         403
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BXM7,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         90
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1L5"
FT   MOD_RES         139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1L5"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1L5"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810W7"
FT   MOD_RES         351
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810W7"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810W7"
FT   MOD_RES         893
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1L5"
FT   MOD_RES         952
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810W7"
FT   MOD_RES         1413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810W7"
FT   VARIANT         93
FT                   /note="S -> L (in a patient with neurodevelopmental
FT                   abnormalities; de novo variant; unknown pathological
FT                   significance; dbSNP:rs878853165)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081872"
FT   VARIANT         98
FT                   /note="G -> V (in a patient with neurodevelopmental
FT                   abnormalities; de novo variant; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081873"
FT   VARIANT         195
FT                   /note="Missing (in MCCCHCM; unknown pathological
FT                   significance; dbSNP:rs1568408280)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081874"
FT   VARIANT         269
FT                   /note="A -> T (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040768"
FT   VARIANT         277
FT                   /note="Missing (in MCCCHCM; dbSNP:rs1568409494)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081875"
FT   VARIANT         279
FT                   /note="Missing (in MCCCHCM; expression of this variant in
FT                   transgenic mice results in thicker corpus callosum,
FT                   hypoplastic cortex and hypoplastic cerebellum)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081876"
FT   VARIANT         517
FT                   /note="G -> S (in MCCCHCM; dbSNP:rs1568413207)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081877"
FT   VARIANT         915
FT                   /note="A -> T (in a patient with neurodevelopmental
FT                   abnormalities; de novo variant; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081878"
FT   VARIANT         1048
FT                   /note="A -> S (in dbSNP:rs35052801)"
FT                   /id="VAR_051644"
FT   VARIANT         1177
FT                   /note="P -> R (in a patient with neurodevelopmental
FT                   abnormalities; de novo variant; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30449657"
FT                   /id="VAR_081879"
FT   VARIANT         1240
FT                   /note="H -> Y (in an ovarian serous carcinoma sample;
FT                   somatic mutation; dbSNP:rs1411105125)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040769"
FT   VARIANT         1292
FT                   /note="P -> S (in dbSNP:rs35071862)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040770"
FT   HELIX           189..202
FT                   /evidence="ECO:0007829|PDB:2M9X"
FT   HELIX           216..237
FT                   /evidence="ECO:0007829|PDB:2M9X"
FT   HELIX           242..261
FT                   /evidence="ECO:0007829|PDB:2M9X"
FT   HELIX           268..281
FT                   /evidence="ECO:0007829|PDB:2M9X"
FT   STRAND          968..971
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   STRAND          973..975
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   STRAND          978..987
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   STRAND          994..1003
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   HELIX           1008..1012
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   STRAND          1019..1023
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   HELIX           1033..1042
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   TURN            1043..1045
FT                   /evidence="ECO:0007829|PDB:3PS4"
FT   STRAND          1046..1052
FT                   /evidence="ECO:0007829|PDB:3PS4"
SQ   SEQUENCE   1570 AA;  170677 MW;  189D24AE07B62A1E CRC64;
     MSDSLWTALS NFSMPSFPGG SMFRRTKSCR TSNRKSLILT STSPTLPRPH SPLPGHLGSS
     PLDSPRNFSP NTPAHFSFAS SRRADGRRWS LASLPSSGYG TNTPSSTVSS SCSSQERLHQ
     LPYQPTVDEL HFLSKHFGST ESITDEDGGR RSPAVRPRSR SLSPGRSPSS YDNEIVMMNH
     VYKERFPKAT AQMEEKLRDF TRAYEPDSVL PLADGVLSFI HHQIIELARD CLTKSRDGLI
     TTVYFYELQE NLEKLLQDAY ERSESLEVAF VTQLVKKLLI IISRPARLLE CLEFNPEEFY
     HLLEAAEGHA KEGHLVKTDI PRYIIRQLGL TRDPFPDVVH LEEQDSGGSN TPEQDDLSEG
     RSSKAKKPPG ENDFDTIKLI SNGAYGAVYL VRHRDTRQRF AMKKINKQNL ILRNQIQQAF
     VERDILTFAE NPFVVGMFCS FETRRHLCMV MEYVEGGDCA TLLKNIGALP VEMARMYFAE
     TVLALEYLHN YGIVHRDLKP DNLLITSMGH IKLTDFGLSK MGLMSLTTNL YEGHIEKDAR
     EFLDKQVCGT PEYIAPEVIL RQGYGKPVDW WAMGIILYEF LVGCVPFFGD TPEELFGQVI
     SDDILWPEGD EALPTEAQLL ISSLLQTNPL VRLGAGGAFE VKQHSFFRDL DWTGLLRQKA
     EFIPHLESED DTSYFDTRSD RYHHVNSYDE DDTTEEEPVE IRQFSSCSPR FSKVYSSMEQ
     LSQHEPKTPV AAAGSSKREP STKGPEEKVA GKREGLGGLT LREKTWRGGS PEIKRFSASE
     ASFLEGEASP PLGARRRFSA LLEPSRFSAP QEDEDEARLR RPPRPSSDPA GSLDARAPKE
     ETQGEGTSSA GDSEATDRPR PGDLCPPSKD GDASGPRATN DLVLRRARHQ QMSGDVAVEK
     RPSRTGGKVI KSASATALSV MIPAVDPHGS SPLASPMSPR SLSSNPSSRD SSPSRDYSPA
     VSGLRSPITI QRSGKKYGFT LRAIRVYMGD TDVYSVHHIV WHVEEGGPAQ EAGLCAGDLI
     THVNGEPVHG MVHPEVVELI LKSGNKVAVT TTPFENTSIR IGPARRSSYK AKMARRNKRP
     SAKEGQESKK RSSLFRKITK QSNLLHTSRS LSSLNRSLSS SDSLPGSPTH GLPARSPTHS
     YRSTPDSAYL GASSQSSSPA SSTPNSPASS ASHHIRPSTL HGLSPKLHRQ YRSARCKSAG
     NIPLSPLAHT PSPTQASPPP LPGHTVGSSH TTQSFPAKLH SSPPVVRPRP KSAEPPRSPL
     LKRVQSAEKL GASLSADKKG ALRKHSLEVG HPDFRKDFHG ELALHSLAES DGETPPVEGL
     GAPRQVAVRR LGRQESPLSL GADPLLPEGA SRPPVSSKEK ESPGGAEACT PPRATTPGGR
     TLERDVGCTR HQSVQTEDGT GGMARAVAKA ALSPVQEHET GRRSSSGEAG TPLVPIVVEP
     ARPGAKAVVP QPLGADSKGL QEPAPLAPSV PEAPRGRERW VLEVVEERTT LSGPRSKPAS
     PKLSPEPQTP SLAPAKCSAP SSAVTPVPPA SLLGSGTKPQ VGLTSRCPAE AVPPAGLTKK
     GVSSPAPPGP
//
